BioPlus Acquisition Corp. (BIOS)

NASDAQ: BIOS · IEX Real-Time Price · USD
10.05
0.00 (0.00%)
At close: Oct 3, 2022 12:00 AM
10.03
-0.02 (-0.20%)
After-hours: Oct 4, 2022 4:00 PM EDT
0.00%
Market Cap 294.56M
Revenue (ttm) n/a
Net Income (ttm) -114,139
Shares Out 29.31M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1
Open 10.05
Previous Close 10.05
Day's Range 10.05 - 10.05
52-Week Range 9.78 - 10.14
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About BIOS

BioPlus Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses in the life sciences industry. The company was incorporated in 2021 and is based in New York, New York. [Read more...]

Industry Blank Check / SPAC
IPO Date Dec 3, 2021
Employees 2,021
Stock Exchange NASDAQ
Ticker Symbol BIOS
Full Company Profile

News

BioPlus Acquisition Corp. Announces Pricing of Upsized $200,000,000 Initial Public Offering

NEW YORK, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioPlus Acquisition Corp. (the “Company”) announced today that it priced its upsized initial public offering of 20,000,000 units at $10.00 per unit. The units...

9 months ago - GlobeNewsWire

Option Care Health Completes Reverse Stock Split and Ticker Symbol Change

BANNOCKBURN, Ill., Feb. 03, 2020 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate si...

2 years ago - GlobeNewsWire

Option Care (BIOS) Down 12% Since Last Earnings Report: Can It Rebound?

Option Care (BIOS) reported earnings 30 days ago. What's next for the stock?

2 years ago - Zacks Investment Research

Option Care Health (BIOS) Surges: Stock Moves 7.3% Higher

Option Care Health (BIOS) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

2 years ago - Zacks Investment Research

Option Care is the Preferred Provider of Haemophilia Treatment

Option Care Health (BIOS) can currently access all hemophilia factor treatments.

2 years ago - Zacks Investment Research

Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment

National leader in treating bleeding disorders offers personalized, high-quality patient care National leader in treating bleeding disorders offers personalized, high-quality patient care

2 years ago - GlobeNewsWire

Option Care Health (BIOS) Q3 Earnings Meet, Revenues Top

Albeit Option Care Health (BIOS) is yet to reap material benefits from its merger-related synergies, the reporting of a positive gross margin in third-quarter results is encouraging for investors.

2 years ago - Zacks Investment Research

Option Care (BIOS) Reports Q3 Loss, Tops Revenue Estimates

Option Care (BIOS) delivered earnings and revenue surprises of 0.00% and 17.94%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

2 years ago - Zacks Investment Research

Option Care (BIOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Option Care (BIOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 years ago - Zacks Investment Research

Moving Average Crossover Alert: Option Care Health

Option Care Health is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

3 years ago - Zacks Investment Research

Top Ranked Momentum Stocks to Buy for September 12th

Top Ranked Momentum Stocks to Buy for September 12th

Other symbols: PLAB
3 years ago - Zacks Investment Research

BioScrip, Inc. (BIOS) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in BioScrip, Inc. (BIOS).

3 years ago - Zacks Investment Research

BioScrip, Inc.'s Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in BioScrip.

3 years ago - Zacks Investment Research

BioScrip (BIOS) Up 5.2% Since Last Earnings Report: Can It Continue?

BioScrip (BIOS) reported earnings 30 days ago. What's next for the stock?

3 years ago - Zacks Investment Research

BioScrip's Option Care Merger on Track, Q1 Loss Narrows

BioScrip (BIOS) is highly upbeat about the strategic and financial virtues of Option Care consolidation.

3 years ago - Zacks Investment Research

BioScrip (BIOS) May Report Negative Earnings: Know the Trend Ahead of Q1 Release

BioScrip (BIOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

3 years ago - Zacks Investment Research

BioScrip (BIOS) Reports Q1 Loss, Tops Revenue Estimates

BioScrip (BIOS) delivered earnings and revenue surprises of 16.67% and 0.82%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

3 years ago - Zacks Investment Research

Moving Average Crossover Alert: BioScrip

BioScrip, Inc. (BIOS) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

3 years ago - Zacks Investment Research

Why Is BioScrip (BIOS) Down 50.4% Since Last Earnings Report?

BioScrip (BIOS) reported earnings 30 days ago. What's next for the stock?

3 years ago - Zacks Investment Research

BioScrip's stock extends plunge after merger terms disappoint, but analyst recommends remaining bullish

Shares of BioScrip Inc. tumbled 9.0% toward a 9-month low in midday trade Monday.

3 years ago - Market Watch

Why Adobe, BioScrip, and Ascena Retail Group Slumped Today

Earnings and other bad news kept these stocks out of today's rally.

Other symbols: ADBE
3 years ago - The Motley Fool

Why BioScrip Stock Popped and Then Dropped Today

BioScrip's fourth-quarter results and merger with Option Care Enterprises aren't sitting well with shareholders.

3 years ago - The Motley Fool

BioScrip to merge with Option Care, owned by Walgreens and Madison Dearborn

BioScrip Inc. announced Friday a deal to merge with privately held Option Care Enterprises Inc.

Other symbols: WBA
3 years ago - Market Watch

BioScrip's stock soars after merger deal with Option Care, owned by Walgreens and Madison Dearborn

Shares of BioScrip Inc. soared 32% toward a 4-year high in premarket trade Friday.

3 years ago - Market Watch